| # | Drug | Count |
|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 59 |
| 1 | TENOFOVIR DISOPROXIL FUMARATE | 39 |
| 2 | LAMIVUDINE | 25 |
| 3 | LAMIVUDINE ORAL | 25 |
| 4 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 23 |
| 5 | ANTACID | 18 |
| 6 | CALCIUM CARBONATE | 18 |
| 7 | ZOLEDRONIC ACID | 17 |
| 8 | LANSOPRAZOLE | 15 |
| 9 | VALPROIC ACID | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 59 | 0.0464 |
| 1 | IBANDRONATE SODIUM | 10 | 0.0032 |
| 2 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 23 | 0.0027 |
| 3 | FERRIC CARBOXYMALTOSE | 6 | 0.0013 |
| 4 | LAMIVUDINE | 25 | 0.0010 |
| 5 | LEVOCARNITINE | 3 | 0.0008 |
| 6 | ENTECAVIR | 9 | 0.0008 |
| 7 | IRON SUCROSE | 6 | 0.0006 |
| 8 | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | 4 | 0.0006 |
| 9 | ALBENDAZOLE | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carnitine Analog [EPC] | 3 | 0.0008 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 29 | 0.0006 |
| 2 | Parenteral Iron Replacement [EPC] | 6 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 4 | Anthelmintic [EPC] | 1 | 0.0003 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 31 | 0.0003 |
| 6 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Vitamin D3 Analog [EPC] | 4 | 0.0002 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 9 | Somatostatin Analog [EPC] | 1 | 0.0001 |